Home Clinical Topics FDA approves new weight-loss drug

FDA approves new weight-loss drug

Author(s):

On July 17, the U.S. Food and Drug Administration (FDA) approved Qsymia (phentermine and topiramate extended-release) as an addition to a reduced-calorie diet and exercise for chronic weight management. Read More.

LEAVE A REPLY

Please enter your comment!
Please enter your name here